Trademark applications and grants for Daiichi Sankyo Co L T D. Daiichi Sankyo Co L T D has 306 trademark applications. The latest application filed is for "QUANTUM-WT"
Patent Application | Date |
---|---|
KLK5 INHIBITORY PEPTIDE 20220306725 - 17/707857 Nishimiya; Daisuke ;   et al. | 2022-09-29 |
THERAPEUTIC AGENT FOR CANCER HAVING RESISTANCE TO ANTI-CCR4 ANTIBODY 20220280492 - 17/630421 FUJITANI; Sumiaki | 2022-09-08 |
ANTIBODY RECOGNIZING EXTRACELLULAR REGION OF ALK2/ACVR1 20220267453 - 17/629715 KATAGIRI; Takenobu ;   et al. | 2022-08-25 |
METHOD FOR PRODUCING A SPIROOXINDOLE DERIVATIVE 20220259216 - 17/081452 YAMAUCHI; Motoshi ;   et al. | 2022-08-18 |
NOVEL METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE 20220226497 - 17/708988 NISHI; Yoshio ;   et al. | 2022-07-21 |
SEC | 0001446393 | Daiichi Sankyo Co Ltd of JAPAN |
SEC | 0001340156 | Daiichi Sankyo Company, LTD of JAPAN |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.